rs142190071

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_015214.3(DDHD2):​c.1168C>A​(p.Leu390Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,574,176 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L390L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 1 hom. )

Consequence

DDHD2
NM_015214.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.130

Publications

1 publications found
Variant links:
Genes affected
DDHD2 (HGNC:29106): (DDHD domain containing 2) This gene encodes a phospholipase enzyme containing sterile-alpha-motif (SAM), WWE, and DDHD domains. This protein participates in membrane trafficking between the endoplastic reticulum and the Golgi body. Mutations in this gene can cause autosomal recessive spastic paraplegia 54. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
DDHD2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 54
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.045523524).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000394 (6/152292) while in subpopulation EAS AF = 0.00116 (6/5180). AF 95% confidence interval is 0.000504. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DDHD2NM_015214.3 linkc.1168C>A p.Leu390Ile missense_variant Exon 10 of 18 ENST00000397166.7 NP_056029.2 O94830-1B3KPM6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DDHD2ENST00000397166.7 linkc.1168C>A p.Leu390Ile missense_variant Exon 10 of 18 2 NM_015214.3 ENSP00000380352.2 O94830-1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152174
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000601
AC:
14
AN:
232770
AF XY:
0.0000634
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000823
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000128
AC:
182
AN:
1421884
Hom.:
1
Cov.:
26
AF XY:
0.000119
AC XY:
84
AN XY:
708464
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31668
American (AMR)
AF:
0.00
AC:
0
AN:
39240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25360
East Asian (EAS)
AF:
0.00467
AC:
181
AN:
38766
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81146
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53172
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1087988
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152292
Hom.:
0
Cov.:
31
AF XY:
0.0000537
AC XY:
4
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41566
American (AMR)
AF:
0.00
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 54 Uncertain:1
May 08, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 390 of the DDHD2 protein (p.Leu390Ile). This variant is present in population databases (rs142190071, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with DDHD2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
1.3
DANN
Benign
0.92
DEOGEN2
Benign
0.011
T;T;.
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.60
.;T;T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.046
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;L;.
PhyloP100
-0.13
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.025
Sift
Benign
0.091
T;T;D
Sift4G
Benign
0.13
T;T;T
Polyphen
0.0060
B;B;.
Vest4
0.18
MutPred
0.48
Loss of ubiquitination at K395 (P = 0.0716);Loss of ubiquitination at K395 (P = 0.0716);.;
MVP
0.12
MPC
0.18
ClinPred
0.048
T
GERP RS
0.28
Varity_R
0.037
gMVP
0.16
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142190071; hg19: chr8-38105273; API